title: Apolipoprotein-AI-containing particles and atherosclerosis.
authors.affiliation: SERLIA, Institute Pasteur, Lille, France.
authors.forename: J C
authors.initials: JC
authors.lastname: Fruchart
authors.forename: G
authors.initials: G
authors.lastname: Castro
authors.forename: P
authors.initials: P
authors.lastname: Duriez
mesh_terms: D000818:Animals; D030801:Animals, Genetically Modified; D016632:Apolipoprotein A-I / Q000378:metabolism*; D016633:Apolipoprotein A-II / Q000378:metabolism; D001161:Arteriosclerosis / Q000378:metabolism*; D003324:Coronary Artery Disease / Q000378:metabolism; D004041:Dietary Fats / Q000494:pharmacology; D006801:Humans; D006951:Hyperlipoproteinemias / Q000378:metabolism; D000960:Hypolipidemic Agents / Q000494:pharmacology; D008136:Longevity
chemical_list: D016632:Apolipoprotein A-I; D016633:Apolipoprotein A-II; D004041:Dietary Fats; D000960:Hypolipidemic Agents